ERYP News and Press, Erytech Pharma S.A.

2023-06-27 10:04:57 ET ERYTECH ( NASDAQ: ERYP ) and PHERECYDES announced on Tuesday merger and name change to PHAXIAM Therapeutics. Press Release For further details see: ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

2023-05-11 08:36:16 ET ImmunityBio IBRX -58% after FDA snub for cancer therapy Guardforce AI Co GFAI -34% on pricing $12M offering . Sonos SONO -23% after Q2 earning release . PacWest Bancorp PACW -23% after pledging more collateral to discount wi...

2023-05-09 09:56:46 ET A French %Biotech company is making some major waves so far during Tuesday’s session after it was announced that the company and Pherecydes intend to merge their operations and relocate all teams to the company’s Lyon location. The merger is set to c...

2023-04-17 16:21:25 ET ERYTECH Pharma said it had received approval from the Nasdaq to transfer the listing of its american depositary shares from the Nasdaq Global Select Market to The Nasdaq Capital Market. The transfer took effect as of the beginning of business on April 14. Th...

Erytech Pharma ( NASDAQ: ERYP ) said it had received a notification from Nasdaq indicating that it was no longer in compliance with the listing rules based on closing bid price of less than $1 per share for tits American Depositary Shares for the prior 30 consecutive business...

ERYTECH Pharma S.A. (ERYP) Q2 2022 Results Conference Call September 13, 2022 08:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial and Chief Operating Officer Dr. Iman El-Hariry - Chief Medical Officer Conference...

French biotech ERYTECH Pharma S.A. ( NASDAQ: ERYP ) announced Wednesday that it would no longer seek U.S. approval for Graspa in hypersensitive acute lymphoblastic leukemia (ALL) following the feedback the company received from the FDA. Chief Executive Gil Beyen noted that...

The following slide deck was published by ERYTECH Pharma S.A. in conjunction with this event. For further details see: ERYTECH Pharma (ERYP) Investor Presentation - Slideshow

ERYTECH Pharma S.A. (ERYP) Q1 2022 Earnings Conference Call May 13, 2022, 8:30 AM ET Company Participants Gil Beyen – Chief Executive Officer Eric Soyer – Chief Financial and Chief Operating Officer Dr. Iman El-Hariry – Chief Medical Officer Conference Call Participants B...

The following slide deck was published by ERYTECH Pharma S.A. in conjunction with their 2022 Q1 earnings call. For further details see: ERYTECH Pharma S.A. 2022 Q1 - Results - Earnings Call Presentation